Home/Pipeline/RN1871

RN1871

Hypertension (AGT)

Phase 1Active

Key Facts

Indication
Hypertension (AGT)
Phase
Phase 1
Status
Active
Company

About Rona Therapeutics

A clinical-stage biotech developing long-acting siRNA therapeutics for metabolic and degenerative diseases using proprietary liver and extrahepatic delivery platforms.

View full company profile